Alnylam PharmaceuticalsALNY 
$243.250.41%24h
0.41%24h
Global rank568
Market cap$30.38B
Change 7d-3.61%
YTD Performance-
SP500 benchmark
P/E-69.11
P/S16.62
Revenue$1.83B
Earnings-$440.24M
Dividend yield-
Main Sector
Healthcare
Alnylam Pharmaceuticals ALNY Operating Margins
Operating Margin in 2022: -0.15%
According to Alnylam Pharmaceuticals latest financial reports the company has an operating margin of -0.15%, an decrease of -79.61% to 2022. At the end of 2022 company had an operating margin of -0.76%.
Alnylam Pharmaceuticals Operating Margin from 2020 to 2025
-
Value:-
ALNY Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -0.15% | -79.61% |
| 2022 | -0.76% | -9.84% |
| 2021 | -0.84% | -50.07% |
| 2020 | -1.68% | - |
View the highest operating margin companies 
